1型糖尿病诊疗技术新进展  

Progress in diagnosis and treatment of type 1 diabetes mellitus

作　　者：王冰[1] 高政南[1] WANG Bing;GAO Zhengnan(Department of Endocrine,Dalian Municipal Central Hospital,Dalian 116033,China)

机构地区：[1]大连市中心医院内分泌科,辽宁大连116033

出　　处：《大连医科大学学报》2021年第3期193-197,共5页Journal of Dalian Medical University

基　　金：国家科技部科技支撑课题项目(2013BAI09B13)。

摘　　要：1型糖尿病(type 1 diabetes mellitus,T1DM)是一种由于胰岛β细胞损伤,导致胰岛素绝对缺乏的自身免疫性疾病。良好的血糖控制可以降低T1DM患者并发症的发生风险,技术进步是T1DM患者实现良好血糖管理的重要前提。随着连续血糖监测系统(continue glucose monitoring system,CGMS)的进一步改善,更多、更先进的自动胰岛素输送系统的出现,在未来的5年里,T1DM治疗技术有望取得飞速进展。Type 1 diabetes(T1 DM)is an autoimmune disease characterized by deficient insulin production which due to dysfunction of isletβ-cell.Proper glycemic controlhas been thought to prevent or delay the complications of T1 DM and technological advances have had an important prerequisite for the management of T1 DM.In the next 5 years,with improvements in continuous glucose monitoring and more available choices of systems that automate insulin delivery advances are expected in technology for the management of T1 DM.

关 键 词：1型糖尿病 持续皮下输注胰岛素 连续血糖监测系统 

分 类 号：R587.1[医药卫生—内分泌]